By now you might have seen that the Food and Drug Administration has scheduled a two-day public meeting to invite patients, providers and any champion of women's sexual health to discuss the lack of medical treatment options for women's sexual dysfunction. What you might not have seen is that this move follows a public outcry from lawmakers and women’s health and right groups about the seeming gender disparity. While women do not have a single approved drug for their most common issue - HSDD or low sexual desire causing distress - the FDA has approved over 20 drugs at this point that are marketed for male sexual dysfunction. See what the publication that goes to members of Congress reported on this issue just this week:
Over the course of a woman’s lifetime, approximately 1 in 8 women will be diagnosed with breast cancer. Most women are concerned about their personal risk for developing cancer and what they can do themselves to reduce their chances of getting the disease.
Miami, FL and New York, NY, September 18, 2013 – Noven Pharmaceuticals, Inc., today announced the publication of resultsfrom its two Phase 3 clinical studies in Menopause, the peer-reviewed, scientific journal of The North American Menopause Society. Brisdelle™, paroxetine capsules, 7.5 mg/day, was approved by the United States Food and Drug Administration in June 2013, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, commonly referred to as hot flashes and night sweats.
A study in the Journal of the American Medical Association (JAMA, April 6,2011)) sheds new light on taking estrogen. Here is what it means to you.
Estrogen versus Estrogen and Progesterone and Uterine Cancer
Like all medications, estrogen is a powerful hormone with benefits and risks that have to be weighed and personalized for each woman. Forty years ago estrogen was so popular and considered so beneficial that almost all women were encouraged to take it from the time of menopause until death. Unfortunately, it was found that estrogen alone can cause cancer of the uterus. Women who have had a hysterectomy and had their uterus removed don’t have this problem.
Then researchers discovered that women who take daily estrogen combined with progesterone for at least 10 days of the month did not get uterine cancer. There were some risks of blood clots and strokes, but overall it was believed that estrogen plus progesterone protected the uterus from uterine cancer and estrogen helped to prevent heart disease. The heart disease part of this changed with more research.